Taking medication to treat attention deficit hyperactivity disorder (ADHD) in childhood does not affect the risk of substance abuse later in life, according to a new study. Earlier research indicated children who took ADHD drugs had a reduced risk of substance abuse, The New York Times reports.
Category results for "Research"
Researchers at the University of Michigan will try to document the impact of medical marijuana, with a $2.2 million grant from the National Institute on Drug Abuse.
A new study finds little evidence that mothers’ use of cocaine during pregnancy in the 1980s led to a proliferation of “crack babies,” the Associated Press reports.
Scientists at Johns Hopkins University have identified a compound that stopped mice addicted to cocaine from wanting the drug. The compound has been proven safe for humans and is undergoing further animal testing, in preparation for possible clinical trials for people addicted to cocaine.
The earlier a person starts drinking, the greater the chance he or she will consume more alcohol later in life, according to a new study of humans and rats. People who start drinking during puberty consume more alcohol later in life than those who start drinking later.
Female college students are more likely than their male peers to drink more alcohol than is recommended by government guidelines, Harvard University researchers have found.
People who drink heavily and smoke may have more signs of early aging of the brain, including problems with memory, quick thinking and problem solving, compared with heavy drinkers who are nonsmokers.
A new study finds a connection between post-traumatic stress disorder and the number of cannabinoid receptors in the brain. These receptors are activated when a person uses marijuana.
In hotels that allow smoking in some rooms, nicotine residue ends up in all rooms, even those labeled “non-smoking,” a new study finds.
An experimental anti-cocaine vaccine blocks the drug from reaching the brain, according to a study of non-human primates. Scientists at Weill Cornell Medical Center in New York say human trials of the vaccine may begin within a year.